Global IBS Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global IBS Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.
Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.
The Global Info Research report includes an overview of the development of the IBS Treatment industry chain, the market status of Hospitals (IBS-D, IBS-C), Clinics (IBS-D, IBS-C), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IBS Treatment.
Regionally, the report analyzes the IBS Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IBS Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IBS Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IBS Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., IBS-D, IBS-C).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IBS Treatment market.
Regional Analysis: The report involves examining the IBS Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IBS Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IBS Treatment:
Company Analysis: Report covers individual IBS Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IBS Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to IBS Treatment. It assesses the current state, advancements, and potential future developments in IBS Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IBS Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IBS Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe IBS Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IBS Treatment, with revenue, gross margin and global market share of IBS Treatment from 2019 to 2024.
Chapter 3, the IBS Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and IBS Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IBS Treatment.
Chapter 13, to describe IBS Treatment research findings and conclusion.
Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.
Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.
The Global Info Research report includes an overview of the development of the IBS Treatment industry chain, the market status of Hospitals (IBS-D, IBS-C), Clinics (IBS-D, IBS-C), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IBS Treatment.
Regionally, the report analyzes the IBS Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IBS Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IBS Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IBS Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., IBS-D, IBS-C).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IBS Treatment market.
Regional Analysis: The report involves examining the IBS Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IBS Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IBS Treatment:
Company Analysis: Report covers individual IBS Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IBS Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to IBS Treatment. It assesses the current state, advancements, and potential future developments in IBS Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IBS Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IBS Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- IBS-D
- IBS-C
- IBS-M
- Hospitals
- Clinics
- Research Laboratories
- Allergan (Ireland)
- Sucampo Pharmaceuticals (U.S.)
- Ironwood Pharmaceuticals (U.S.)
- Astellas Pharma (Japan)
- Bausch Health
- Abbott Laboratories (U.S.)
- Synergy Pharmaceuticals (U.S.)
- Ardelyx (U.S.)
- Nestle (Switzerland)
- Sebela Pharmaceuticals (Ireland)
- Probi (Sweden)
- Alfasigma USA (Italy)
- RedHill Biopharma (Israel)
- AstraZeneca (U.K)
- Ipsen (France)
- Novartis (Switzerland)
- Takeda Pharmaceutical Company (Japan)
- Synthetic Biologics (U.S.)
- Protagonist Therapeutics (U.S.)
- Pfizer (U.S.)
- Lexicon Pharmaceuticals (U.S.)
- Innovate Biopharmaceuticals (U.S.)
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe IBS Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IBS Treatment, with revenue, gross margin and global market share of IBS Treatment from 2019 to 2024.
Chapter 3, the IBS Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and IBS Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IBS Treatment.
Chapter 13, to describe IBS Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of IBS Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of IBS Treatment by Type
1.3.1 Overview: Global IBS Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global IBS Treatment Consumption Value Market Share by Type in 2023
1.3.3 IBS-D
1.3.4 IBS-C
1.3.5 IBS-M
1.4 Global IBS Treatment Market by Application
1.4.1 Overview: Global IBS Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Research Laboratories
1.5 Global IBS Treatment Market Size & Forecast
1.6 Global IBS Treatment Market Size and Forecast by Region
1.6.1 Global IBS Treatment Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global IBS Treatment Market Size by Region, (2019-2030)
1.6.3 North America IBS Treatment Market Size and Prospect (2019-2030)
1.6.4 Europe IBS Treatment Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific IBS Treatment Market Size and Prospect (2019-2030)
1.6.6 South America IBS Treatment Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa IBS Treatment Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Allergan (Ireland)
2.1.1 Allergan (Ireland) Details
2.1.2 Allergan (Ireland) Major Business
2.1.3 Allergan (Ireland) IBS Treatment Product and Solutions
2.1.4 Allergan (Ireland) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Allergan (Ireland) Recent Developments and Future Plans
2.2 Sucampo Pharmaceuticals (U.S.)
2.2.1 Sucampo Pharmaceuticals (U.S.) Details
2.2.2 Sucampo Pharmaceuticals (U.S.) Major Business
2.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.2.4 Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sucampo Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.3 Ironwood Pharmaceuticals (U.S.)
2.3.1 Ironwood Pharmaceuticals (U.S.) Details
2.3.2 Ironwood Pharmaceuticals (U.S.) Major Business
2.3.3 Ironwood Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.3.4 Ironwood Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Ironwood Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.4 Astellas Pharma (Japan)
2.4.1 Astellas Pharma (Japan) Details
2.4.2 Astellas Pharma (Japan) Major Business
2.4.3 Astellas Pharma (Japan) IBS Treatment Product and Solutions
2.4.4 Astellas Pharma (Japan) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Astellas Pharma (Japan) Recent Developments and Future Plans
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business
2.5.3 Bausch Health IBS Treatment Product and Solutions
2.5.4 Bausch Health IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bausch Health Recent Developments and Future Plans
2.6 Abbott Laboratories (U.S.)
2.6.1 Abbott Laboratories (U.S.) Details
2.6.2 Abbott Laboratories (U.S.) Major Business
2.6.3 Abbott Laboratories (U.S.) IBS Treatment Product and Solutions
2.6.4 Abbott Laboratories (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Laboratories (U.S.) Recent Developments and Future Plans
2.7 Synergy Pharmaceuticals (U.S.)
2.7.1 Synergy Pharmaceuticals (U.S.) Details
2.7.2 Synergy Pharmaceuticals (U.S.) Major Business
2.7.3 Synergy Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.7.4 Synergy Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Synergy Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.8 Ardelyx (U.S.)
2.8.1 Ardelyx (U.S.) Details
2.8.2 Ardelyx (U.S.) Major Business
2.8.3 Ardelyx (U.S.) IBS Treatment Product and Solutions
2.8.4 Ardelyx (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Ardelyx (U.S.) Recent Developments and Future Plans
2.9 Nestle (Switzerland)
2.9.1 Nestle (Switzerland) Details
2.9.2 Nestle (Switzerland) Major Business
2.9.3 Nestle (Switzerland) IBS Treatment Product and Solutions
2.9.4 Nestle (Switzerland) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Nestle (Switzerland) Recent Developments and Future Plans
2.10 Sebela Pharmaceuticals (Ireland)
2.10.1 Sebela Pharmaceuticals (Ireland) Details
2.10.2 Sebela Pharmaceuticals (Ireland) Major Business
2.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Product and Solutions
2.10.4 Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sebela Pharmaceuticals (Ireland) Recent Developments and Future Plans
2.11 Probi (Sweden)
2.11.1 Probi (Sweden) Details
2.11.2 Probi (Sweden) Major Business
2.11.3 Probi (Sweden) IBS Treatment Product and Solutions
2.11.4 Probi (Sweden) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Probi (Sweden) Recent Developments and Future Plans
2.12 Alfasigma USA (Italy)
2.12.1 Alfasigma USA (Italy) Details
2.12.2 Alfasigma USA (Italy) Major Business
2.12.3 Alfasigma USA (Italy) IBS Treatment Product and Solutions
2.12.4 Alfasigma USA (Italy) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Alfasigma USA (Italy) Recent Developments and Future Plans
2.13 RedHill Biopharma (Israel)
2.13.1 RedHill Biopharma (Israel) Details
2.13.2 RedHill Biopharma (Israel) Major Business
2.13.3 RedHill Biopharma (Israel) IBS Treatment Product and Solutions
2.13.4 RedHill Biopharma (Israel) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 RedHill Biopharma (Israel) Recent Developments and Future Plans
2.14 AstraZeneca (U.K)
2.14.1 AstraZeneca (U.K) Details
2.14.2 AstraZeneca (U.K) Major Business
2.14.3 AstraZeneca (U.K) IBS Treatment Product and Solutions
2.14.4 AstraZeneca (U.K) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 AstraZeneca (U.K) Recent Developments and Future Plans
2.15 Ipsen (France)
2.15.1 Ipsen (France) Details
2.15.2 Ipsen (France) Major Business
2.15.3 Ipsen (France) IBS Treatment Product and Solutions
2.15.4 Ipsen (France) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Ipsen (France) Recent Developments and Future Plans
2.16 Novartis (Switzerland)
2.16.1 Novartis (Switzerland) Details
2.16.2 Novartis (Switzerland) Major Business
2.16.3 Novartis (Switzerland) IBS Treatment Product and Solutions
2.16.4 Novartis (Switzerland) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Novartis (Switzerland) Recent Developments and Future Plans
2.17 Takeda Pharmaceutical Company (Japan)
2.17.1 Takeda Pharmaceutical Company (Japan) Details
2.17.2 Takeda Pharmaceutical Company (Japan) Major Business
2.17.3 Takeda Pharmaceutical Company (Japan) IBS Treatment Product and Solutions
2.17.4 Takeda Pharmaceutical Company (Japan) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Takeda Pharmaceutical Company (Japan) Recent Developments and Future Plans
2.18 Synthetic Biologics (U.S.)
2.18.1 Synthetic Biologics (U.S.) Details
2.18.2 Synthetic Biologics (U.S.) Major Business
2.18.3 Synthetic Biologics (U.S.) IBS Treatment Product and Solutions
2.18.4 Synthetic Biologics (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Synthetic Biologics (U.S.) Recent Developments and Future Plans
2.19 Protagonist Therapeutics (U.S.)
2.19.1 Protagonist Therapeutics (U.S.) Details
2.19.2 Protagonist Therapeutics (U.S.) Major Business
2.19.3 Protagonist Therapeutics (U.S.) IBS Treatment Product and Solutions
2.19.4 Protagonist Therapeutics (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Protagonist Therapeutics (U.S.) Recent Developments and Future Plans
2.20 Pfizer (U.S.)
2.20.1 Pfizer (U.S.) Details
2.20.2 Pfizer (U.S.) Major Business
2.20.3 Pfizer (U.S.) IBS Treatment Product and Solutions
2.20.4 Pfizer (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Pfizer (U.S.) Recent Developments and Future Plans
2.21 Lexicon Pharmaceuticals (U.S.)
2.21.1 Lexicon Pharmaceuticals (U.S.) Details
2.21.2 Lexicon Pharmaceuticals (U.S.) Major Business
2.21.3 Lexicon Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.21.4 Lexicon Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Lexicon Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.22 Innovate Biopharmaceuticals (U.S.)
2.22.1 Innovate Biopharmaceuticals (U.S.) Details
2.22.2 Innovate Biopharmaceuticals (U.S.) Major Business
2.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.22.4 Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Innovate Biopharmaceuticals (U.S.) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global IBS Treatment Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of IBS Treatment by Company Revenue
3.2.2 Top 3 IBS Treatment Players Market Share in 2023
3.2.3 Top 6 IBS Treatment Players Market Share in 2023
3.3 IBS Treatment Market: Overall Company Footprint Analysis
3.3.1 IBS Treatment Market: Region Footprint
3.3.2 IBS Treatment Market: Company Product Type Footprint
3.3.3 IBS Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global IBS Treatment Consumption Value and Market Share by Type (2019-2024)
4.2 Global IBS Treatment Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global IBS Treatment Consumption Value Market Share by Application (2019-2024)
5.2 Global IBS Treatment Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America IBS Treatment Consumption Value by Type (2019-2030)
6.2 North America IBS Treatment Consumption Value by Application (2019-2030)
6.3 North America IBS Treatment Market Size by Country
6.3.1 North America IBS Treatment Consumption Value by Country (2019-2030)
6.3.2 United States IBS Treatment Market Size and Forecast (2019-2030)
6.3.3 Canada IBS Treatment Market Size and Forecast (2019-2030)
6.3.4 Mexico IBS Treatment Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe IBS Treatment Consumption Value by Type (2019-2030)
7.2 Europe IBS Treatment Consumption Value by Application (2019-2030)
7.3 Europe IBS Treatment Market Size by Country
7.3.1 Europe IBS Treatment Consumption Value by Country (2019-2030)
7.3.2 Germany IBS Treatment Market Size and Forecast (2019-2030)
7.3.3 France IBS Treatment Market Size and Forecast (2019-2030)
7.3.4 United Kingdom IBS Treatment Market Size and Forecast (2019-2030)
7.3.5 Russia IBS Treatment Market Size and Forecast (2019-2030)
7.3.6 Italy IBS Treatment Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific IBS Treatment Consumption Value by Type (2019-2030)
8.2 Asia-Pacific IBS Treatment Consumption Value by Application (2019-2030)
8.3 Asia-Pacific IBS Treatment Market Size by Region
8.3.1 Asia-Pacific IBS Treatment Consumption Value by Region (2019-2030)
8.3.2 China IBS Treatment Market Size and Forecast (2019-2030)
8.3.3 Japan IBS Treatment Market Size and Forecast (2019-2030)
8.3.4 South Korea IBS Treatment Market Size and Forecast (2019-2030)
8.3.5 India IBS Treatment Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia IBS Treatment Market Size and Forecast (2019-2030)
8.3.7 Australia IBS Treatment Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America IBS Treatment Consumption Value by Type (2019-2030)
9.2 South America IBS Treatment Consumption Value by Application (2019-2030)
9.3 South America IBS Treatment Market Size by Country
9.3.1 South America IBS Treatment Consumption Value by Country (2019-2030)
9.3.2 Brazil IBS Treatment Market Size and Forecast (2019-2030)
9.3.3 Argentina IBS Treatment Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa IBS Treatment Consumption Value by Type (2019-2030)
10.2 Middle East & Africa IBS Treatment Consumption Value by Application (2019-2030)
10.3 Middle East & Africa IBS Treatment Market Size by Country
10.3.1 Middle East & Africa IBS Treatment Consumption Value by Country (2019-2030)
10.3.2 Turkey IBS Treatment Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia IBS Treatment Market Size and Forecast (2019-2030)
10.3.4 UAE IBS Treatment Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 IBS Treatment Market Drivers
11.2 IBS Treatment Market Restraints
11.3 IBS Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 IBS Treatment Industry Chain
12.2 IBS Treatment Upstream Analysis
12.3 IBS Treatment Midstream Analysis
12.4 IBS Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of IBS Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of IBS Treatment by Type
1.3.1 Overview: Global IBS Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global IBS Treatment Consumption Value Market Share by Type in 2023
1.3.3 IBS-D
1.3.4 IBS-C
1.3.5 IBS-M
1.4 Global IBS Treatment Market by Application
1.4.1 Overview: Global IBS Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Research Laboratories
1.5 Global IBS Treatment Market Size & Forecast
1.6 Global IBS Treatment Market Size and Forecast by Region
1.6.1 Global IBS Treatment Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global IBS Treatment Market Size by Region, (2019-2030)
1.6.3 North America IBS Treatment Market Size and Prospect (2019-2030)
1.6.4 Europe IBS Treatment Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific IBS Treatment Market Size and Prospect (2019-2030)
1.6.6 South America IBS Treatment Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa IBS Treatment Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Allergan (Ireland)
2.1.1 Allergan (Ireland) Details
2.1.2 Allergan (Ireland) Major Business
2.1.3 Allergan (Ireland) IBS Treatment Product and Solutions
2.1.4 Allergan (Ireland) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Allergan (Ireland) Recent Developments and Future Plans
2.2 Sucampo Pharmaceuticals (U.S.)
2.2.1 Sucampo Pharmaceuticals (U.S.) Details
2.2.2 Sucampo Pharmaceuticals (U.S.) Major Business
2.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.2.4 Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sucampo Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.3 Ironwood Pharmaceuticals (U.S.)
2.3.1 Ironwood Pharmaceuticals (U.S.) Details
2.3.2 Ironwood Pharmaceuticals (U.S.) Major Business
2.3.3 Ironwood Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.3.4 Ironwood Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Ironwood Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.4 Astellas Pharma (Japan)
2.4.1 Astellas Pharma (Japan) Details
2.4.2 Astellas Pharma (Japan) Major Business
2.4.3 Astellas Pharma (Japan) IBS Treatment Product and Solutions
2.4.4 Astellas Pharma (Japan) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Astellas Pharma (Japan) Recent Developments and Future Plans
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business
2.5.3 Bausch Health IBS Treatment Product and Solutions
2.5.4 Bausch Health IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bausch Health Recent Developments and Future Plans
2.6 Abbott Laboratories (U.S.)
2.6.1 Abbott Laboratories (U.S.) Details
2.6.2 Abbott Laboratories (U.S.) Major Business
2.6.3 Abbott Laboratories (U.S.) IBS Treatment Product and Solutions
2.6.4 Abbott Laboratories (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Laboratories (U.S.) Recent Developments and Future Plans
2.7 Synergy Pharmaceuticals (U.S.)
2.7.1 Synergy Pharmaceuticals (U.S.) Details
2.7.2 Synergy Pharmaceuticals (U.S.) Major Business
2.7.3 Synergy Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.7.4 Synergy Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Synergy Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.8 Ardelyx (U.S.)
2.8.1 Ardelyx (U.S.) Details
2.8.2 Ardelyx (U.S.) Major Business
2.8.3 Ardelyx (U.S.) IBS Treatment Product and Solutions
2.8.4 Ardelyx (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Ardelyx (U.S.) Recent Developments and Future Plans
2.9 Nestle (Switzerland)
2.9.1 Nestle (Switzerland) Details
2.9.2 Nestle (Switzerland) Major Business
2.9.3 Nestle (Switzerland) IBS Treatment Product and Solutions
2.9.4 Nestle (Switzerland) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Nestle (Switzerland) Recent Developments and Future Plans
2.10 Sebela Pharmaceuticals (Ireland)
2.10.1 Sebela Pharmaceuticals (Ireland) Details
2.10.2 Sebela Pharmaceuticals (Ireland) Major Business
2.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Product and Solutions
2.10.4 Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sebela Pharmaceuticals (Ireland) Recent Developments and Future Plans
2.11 Probi (Sweden)
2.11.1 Probi (Sweden) Details
2.11.2 Probi (Sweden) Major Business
2.11.3 Probi (Sweden) IBS Treatment Product and Solutions
2.11.4 Probi (Sweden) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Probi (Sweden) Recent Developments and Future Plans
2.12 Alfasigma USA (Italy)
2.12.1 Alfasigma USA (Italy) Details
2.12.2 Alfasigma USA (Italy) Major Business
2.12.3 Alfasigma USA (Italy) IBS Treatment Product and Solutions
2.12.4 Alfasigma USA (Italy) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Alfasigma USA (Italy) Recent Developments and Future Plans
2.13 RedHill Biopharma (Israel)
2.13.1 RedHill Biopharma (Israel) Details
2.13.2 RedHill Biopharma (Israel) Major Business
2.13.3 RedHill Biopharma (Israel) IBS Treatment Product and Solutions
2.13.4 RedHill Biopharma (Israel) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 RedHill Biopharma (Israel) Recent Developments and Future Plans
2.14 AstraZeneca (U.K)
2.14.1 AstraZeneca (U.K) Details
2.14.2 AstraZeneca (U.K) Major Business
2.14.3 AstraZeneca (U.K) IBS Treatment Product and Solutions
2.14.4 AstraZeneca (U.K) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 AstraZeneca (U.K) Recent Developments and Future Plans
2.15 Ipsen (France)
2.15.1 Ipsen (France) Details
2.15.2 Ipsen (France) Major Business
2.15.3 Ipsen (France) IBS Treatment Product and Solutions
2.15.4 Ipsen (France) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Ipsen (France) Recent Developments and Future Plans
2.16 Novartis (Switzerland)
2.16.1 Novartis (Switzerland) Details
2.16.2 Novartis (Switzerland) Major Business
2.16.3 Novartis (Switzerland) IBS Treatment Product and Solutions
2.16.4 Novartis (Switzerland) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Novartis (Switzerland) Recent Developments and Future Plans
2.17 Takeda Pharmaceutical Company (Japan)
2.17.1 Takeda Pharmaceutical Company (Japan) Details
2.17.2 Takeda Pharmaceutical Company (Japan) Major Business
2.17.3 Takeda Pharmaceutical Company (Japan) IBS Treatment Product and Solutions
2.17.4 Takeda Pharmaceutical Company (Japan) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Takeda Pharmaceutical Company (Japan) Recent Developments and Future Plans
2.18 Synthetic Biologics (U.S.)
2.18.1 Synthetic Biologics (U.S.) Details
2.18.2 Synthetic Biologics (U.S.) Major Business
2.18.3 Synthetic Biologics (U.S.) IBS Treatment Product and Solutions
2.18.4 Synthetic Biologics (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Synthetic Biologics (U.S.) Recent Developments and Future Plans
2.19 Protagonist Therapeutics (U.S.)
2.19.1 Protagonist Therapeutics (U.S.) Details
2.19.2 Protagonist Therapeutics (U.S.) Major Business
2.19.3 Protagonist Therapeutics (U.S.) IBS Treatment Product and Solutions
2.19.4 Protagonist Therapeutics (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Protagonist Therapeutics (U.S.) Recent Developments and Future Plans
2.20 Pfizer (U.S.)
2.20.1 Pfizer (U.S.) Details
2.20.2 Pfizer (U.S.) Major Business
2.20.3 Pfizer (U.S.) IBS Treatment Product and Solutions
2.20.4 Pfizer (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Pfizer (U.S.) Recent Developments and Future Plans
2.21 Lexicon Pharmaceuticals (U.S.)
2.21.1 Lexicon Pharmaceuticals (U.S.) Details
2.21.2 Lexicon Pharmaceuticals (U.S.) Major Business
2.21.3 Lexicon Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.21.4 Lexicon Pharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Lexicon Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.22 Innovate Biopharmaceuticals (U.S.)
2.22.1 Innovate Biopharmaceuticals (U.S.) Details
2.22.2 Innovate Biopharmaceuticals (U.S.) Major Business
2.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Product and Solutions
2.22.4 Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Innovate Biopharmaceuticals (U.S.) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global IBS Treatment Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of IBS Treatment by Company Revenue
3.2.2 Top 3 IBS Treatment Players Market Share in 2023
3.2.3 Top 6 IBS Treatment Players Market Share in 2023
3.3 IBS Treatment Market: Overall Company Footprint Analysis
3.3.1 IBS Treatment Market: Region Footprint
3.3.2 IBS Treatment Market: Company Product Type Footprint
3.3.3 IBS Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global IBS Treatment Consumption Value and Market Share by Type (2019-2024)
4.2 Global IBS Treatment Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global IBS Treatment Consumption Value Market Share by Application (2019-2024)
5.2 Global IBS Treatment Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America IBS Treatment Consumption Value by Type (2019-2030)
6.2 North America IBS Treatment Consumption Value by Application (2019-2030)
6.3 North America IBS Treatment Market Size by Country
6.3.1 North America IBS Treatment Consumption Value by Country (2019-2030)
6.3.2 United States IBS Treatment Market Size and Forecast (2019-2030)
6.3.3 Canada IBS Treatment Market Size and Forecast (2019-2030)
6.3.4 Mexico IBS Treatment Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe IBS Treatment Consumption Value by Type (2019-2030)
7.2 Europe IBS Treatment Consumption Value by Application (2019-2030)
7.3 Europe IBS Treatment Market Size by Country
7.3.1 Europe IBS Treatment Consumption Value by Country (2019-2030)
7.3.2 Germany IBS Treatment Market Size and Forecast (2019-2030)
7.3.3 France IBS Treatment Market Size and Forecast (2019-2030)
7.3.4 United Kingdom IBS Treatment Market Size and Forecast (2019-2030)
7.3.5 Russia IBS Treatment Market Size and Forecast (2019-2030)
7.3.6 Italy IBS Treatment Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific IBS Treatment Consumption Value by Type (2019-2030)
8.2 Asia-Pacific IBS Treatment Consumption Value by Application (2019-2030)
8.3 Asia-Pacific IBS Treatment Market Size by Region
8.3.1 Asia-Pacific IBS Treatment Consumption Value by Region (2019-2030)
8.3.2 China IBS Treatment Market Size and Forecast (2019-2030)
8.3.3 Japan IBS Treatment Market Size and Forecast (2019-2030)
8.3.4 South Korea IBS Treatment Market Size and Forecast (2019-2030)
8.3.5 India IBS Treatment Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia IBS Treatment Market Size and Forecast (2019-2030)
8.3.7 Australia IBS Treatment Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America IBS Treatment Consumption Value by Type (2019-2030)
9.2 South America IBS Treatment Consumption Value by Application (2019-2030)
9.3 South America IBS Treatment Market Size by Country
9.3.1 South America IBS Treatment Consumption Value by Country (2019-2030)
9.3.2 Brazil IBS Treatment Market Size and Forecast (2019-2030)
9.3.3 Argentina IBS Treatment Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa IBS Treatment Consumption Value by Type (2019-2030)
10.2 Middle East & Africa IBS Treatment Consumption Value by Application (2019-2030)
10.3 Middle East & Africa IBS Treatment Market Size by Country
10.3.1 Middle East & Africa IBS Treatment Consumption Value by Country (2019-2030)
10.3.2 Turkey IBS Treatment Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia IBS Treatment Market Size and Forecast (2019-2030)
10.3.4 UAE IBS Treatment Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 IBS Treatment Market Drivers
11.2 IBS Treatment Market Restraints
11.3 IBS Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 IBS Treatment Industry Chain
12.2 IBS Treatment Upstream Analysis
12.3 IBS Treatment Midstream Analysis
12.4 IBS Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global IBS Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global IBS Treatment Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global IBS Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global IBS Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Allergan (Ireland) Company Information, Head Office, and Major Competitors
Table 6. Allergan (Ireland) Major Business
Table 7. Allergan (Ireland) IBS Treatment Product and Solutions
Table 8. Allergan (Ireland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Allergan (Ireland) Recent Developments and Future Plans
Table 10. Sucampo Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 11. Sucampo Pharmaceuticals (U.S.) Major Business
Table 12. Sucampo Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 13. Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sucampo Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 15. Ironwood Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 16. Ironwood Pharmaceuticals (U.S.) Major Business
Table 17. Ironwood Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 18. Ironwood Pharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Ironwood Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 20. Astellas Pharma (Japan) Company Information, Head Office, and Major Competitors
Table 21. Astellas Pharma (Japan) Major Business
Table 22. Astellas Pharma (Japan) IBS Treatment Product and Solutions
Table 23. Astellas Pharma (Japan) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Astellas Pharma (Japan) Recent Developments and Future Plans
Table 25. Bausch Health Company Information, Head Office, and Major Competitors
Table 26. Bausch Health Major Business
Table 27. Bausch Health IBS Treatment Product and Solutions
Table 28. Bausch Health IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bausch Health Recent Developments and Future Plans
Table 30. Abbott Laboratories (U.S.) Company Information, Head Office, and Major Competitors
Table 31. Abbott Laboratories (U.S.) Major Business
Table 32. Abbott Laboratories (U.S.) IBS Treatment Product and Solutions
Table 33. Abbott Laboratories (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Abbott Laboratories (U.S.) Recent Developments and Future Plans
Table 35. Synergy Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 36. Synergy Pharmaceuticals (U.S.) Major Business
Table 37. Synergy Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 38. Synergy Pharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Synergy Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 40. Ardelyx (U.S.) Company Information, Head Office, and Major Competitors
Table 41. Ardelyx (U.S.) Major Business
Table 42. Ardelyx (U.S.) IBS Treatment Product and Solutions
Table 43. Ardelyx (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Ardelyx (U.S.) Recent Developments and Future Plans
Table 45. Nestle (Switzerland) Company Information, Head Office, and Major Competitors
Table 46. Nestle (Switzerland) Major Business
Table 47. Nestle (Switzerland) IBS Treatment Product and Solutions
Table 48. Nestle (Switzerland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Nestle (Switzerland) Recent Developments and Future Plans
Table 50. Sebela Pharmaceuticals (Ireland) Company Information, Head Office, and Major Competitors
Table 51. Sebela Pharmaceuticals (Ireland) Major Business
Table 52. Sebela Pharmaceuticals (Ireland) IBS Treatment Product and Solutions
Table 53. Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sebela Pharmaceuticals (Ireland) Recent Developments and Future Plans
Table 55. Probi (Sweden) Company Information, Head Office, and Major Competitors
Table 56. Probi (Sweden) Major Business
Table 57. Probi (Sweden) IBS Treatment Product and Solutions
Table 58. Probi (Sweden) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Probi (Sweden) Recent Developments and Future Plans
Table 60. Alfasigma USA (Italy) Company Information, Head Office, and Major Competitors
Table 61. Alfasigma USA (Italy) Major Business
Table 62. Alfasigma USA (Italy) IBS Treatment Product and Solutions
Table 63. Alfasigma USA (Italy) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Alfasigma USA (Italy) Recent Developments and Future Plans
Table 65. RedHill Biopharma (Israel) Company Information, Head Office, and Major Competitors
Table 66. RedHill Biopharma (Israel) Major Business
Table 67. RedHill Biopharma (Israel) IBS Treatment Product and Solutions
Table 68. RedHill Biopharma (Israel) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. RedHill Biopharma (Israel) Recent Developments and Future Plans
Table 70. AstraZeneca (U.K) Company Information, Head Office, and Major Competitors
Table 71. AstraZeneca (U.K) Major Business
Table 72. AstraZeneca (U.K) IBS Treatment Product and Solutions
Table 73. AstraZeneca (U.K) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. AstraZeneca (U.K) Recent Developments and Future Plans
Table 75. Ipsen (France) Company Information, Head Office, and Major Competitors
Table 76. Ipsen (France) Major Business
Table 77. Ipsen (France) IBS Treatment Product and Solutions
Table 78. Ipsen (France) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Ipsen (France) Recent Developments and Future Plans
Table 80. Novartis (Switzerland) Company Information, Head Office, and Major Competitors
Table 81. Novartis (Switzerland) Major Business
Table 82. Novartis (Switzerland) IBS Treatment Product and Solutions
Table 83. Novartis (Switzerland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Novartis (Switzerland) Recent Developments and Future Plans
Table 85. Takeda Pharmaceutical Company (Japan) Company Information, Head Office, and Major Competitors
Table 86. Takeda Pharmaceutical Company (Japan) Major Business
Table 87. Takeda Pharmaceutical Company (Japan) IBS Treatment Product and Solutions
Table 88. Takeda Pharmaceutical Company (Japan) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Takeda Pharmaceutical Company (Japan) Recent Developments and Future Plans
Table 90. Synthetic Biologics (U.S.) Company Information, Head Office, and Major Competitors
Table 91. Synthetic Biologics (U.S.) Major Business
Table 92. Synthetic Biologics (U.S.) IBS Treatment Product and Solutions
Table 93. Synthetic Biologics (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Synthetic Biologics (U.S.) Recent Developments and Future Plans
Table 95. Protagonist Therapeutics (U.S.) Company Information, Head Office, and Major Competitors
Table 96. Protagonist Therapeutics (U.S.) Major Business
Table 97. Protagonist Therapeutics (U.S.) IBS Treatment Product and Solutions
Table 98. Protagonist Therapeutics (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Protagonist Therapeutics (U.S.) Recent Developments and Future Plans
Table 100. Pfizer (U.S.) Company Information, Head Office, and Major Competitors
Table 101. Pfizer (U.S.) Major Business
Table 102. Pfizer (U.S.) IBS Treatment Product and Solutions
Table 103. Pfizer (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Pfizer (U.S.) Recent Developments and Future Plans
Table 105. Lexicon Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 106. Lexicon Pharmaceuticals (U.S.) Major Business
Table 107. Lexicon Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 108. Lexicon Pharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Lexicon Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 110. Innovate Biopharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 111. Innovate Biopharmaceuticals (U.S.) Major Business
Table 112. Innovate Biopharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 113. Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Innovate Biopharmaceuticals (U.S.) Recent Developments and Future Plans
Table 115. Global IBS Treatment Revenue (USD Million) by Players (2019-2024)
Table 116. Global IBS Treatment Revenue Share by Players (2019-2024)
Table 117. Breakdown of IBS Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in IBS Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 119. Head Office of Key IBS Treatment Players
Table 120. IBS Treatment Market: Company Product Type Footprint
Table 121. IBS Treatment Market: Company Product Application Footprint
Table 122. IBS Treatment New Market Entrants and Barriers to Market Entry
Table 123. IBS Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global IBS Treatment Consumption Value (USD Million) by Type (2019-2024)
Table 125. Global IBS Treatment Consumption Value Share by Type (2019-2024)
Table 126. Global IBS Treatment Consumption Value Forecast by Type (2025-2030)
Table 127. Global IBS Treatment Consumption Value by Application (2019-2024)
Table 128. Global IBS Treatment Consumption Value Forecast by Application (2025-2030)
Table 129. North America IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 130. North America IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 131. North America IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 132. North America IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 133. North America IBS Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 134. North America IBS Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 135. Europe IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Europe IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Europe IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 138. Europe IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 139. Europe IBS Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe IBS Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 142. Asia-Pacific IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 143. Asia-Pacific IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 144. Asia-Pacific IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 145. Asia-Pacific IBS Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 146. Asia-Pacific IBS Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 147. South America IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 148. South America IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 149. South America IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 150. South America IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 151. South America IBS Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 152. South America IBS Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Middle East & Africa IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 154. Middle East & Africa IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 155. Middle East & Africa IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 156. Middle East & Africa IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 157. Middle East & Africa IBS Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 158. Middle East & Africa IBS Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 159. IBS Treatment Raw Material
Table 160. Key Suppliers of IBS Treatment Raw Materials
Table 1. Global IBS Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global IBS Treatment Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global IBS Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global IBS Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Allergan (Ireland) Company Information, Head Office, and Major Competitors
Table 6. Allergan (Ireland) Major Business
Table 7. Allergan (Ireland) IBS Treatment Product and Solutions
Table 8. Allergan (Ireland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Allergan (Ireland) Recent Developments and Future Plans
Table 10. Sucampo Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 11. Sucampo Pharmaceuticals (U.S.) Major Business
Table 12. Sucampo Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 13. Sucampo Pharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sucampo Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 15. Ironwood Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 16. Ironwood Pharmaceuticals (U.S.) Major Business
Table 17. Ironwood Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 18. Ironwood Pharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Ironwood Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 20. Astellas Pharma (Japan) Company Information, Head Office, and Major Competitors
Table 21. Astellas Pharma (Japan) Major Business
Table 22. Astellas Pharma (Japan) IBS Treatment Product and Solutions
Table 23. Astellas Pharma (Japan) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Astellas Pharma (Japan) Recent Developments and Future Plans
Table 25. Bausch Health Company Information, Head Office, and Major Competitors
Table 26. Bausch Health Major Business
Table 27. Bausch Health IBS Treatment Product and Solutions
Table 28. Bausch Health IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bausch Health Recent Developments and Future Plans
Table 30. Abbott Laboratories (U.S.) Company Information, Head Office, and Major Competitors
Table 31. Abbott Laboratories (U.S.) Major Business
Table 32. Abbott Laboratories (U.S.) IBS Treatment Product and Solutions
Table 33. Abbott Laboratories (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Abbott Laboratories (U.S.) Recent Developments and Future Plans
Table 35. Synergy Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 36. Synergy Pharmaceuticals (U.S.) Major Business
Table 37. Synergy Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 38. Synergy Pharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Synergy Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 40. Ardelyx (U.S.) Company Information, Head Office, and Major Competitors
Table 41. Ardelyx (U.S.) Major Business
Table 42. Ardelyx (U.S.) IBS Treatment Product and Solutions
Table 43. Ardelyx (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Ardelyx (U.S.) Recent Developments and Future Plans
Table 45. Nestle (Switzerland) Company Information, Head Office, and Major Competitors
Table 46. Nestle (Switzerland) Major Business
Table 47. Nestle (Switzerland) IBS Treatment Product and Solutions
Table 48. Nestle (Switzerland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Nestle (Switzerland) Recent Developments and Future Plans
Table 50. Sebela Pharmaceuticals (Ireland) Company Information, Head Office, and Major Competitors
Table 51. Sebela Pharmaceuticals (Ireland) Major Business
Table 52. Sebela Pharmaceuticals (Ireland) IBS Treatment Product and Solutions
Table 53. Sebela Pharmaceuticals (Ireland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sebela Pharmaceuticals (Ireland) Recent Developments and Future Plans
Table 55. Probi (Sweden) Company Information, Head Office, and Major Competitors
Table 56. Probi (Sweden) Major Business
Table 57. Probi (Sweden) IBS Treatment Product and Solutions
Table 58. Probi (Sweden) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Probi (Sweden) Recent Developments and Future Plans
Table 60. Alfasigma USA (Italy) Company Information, Head Office, and Major Competitors
Table 61. Alfasigma USA (Italy) Major Business
Table 62. Alfasigma USA (Italy) IBS Treatment Product and Solutions
Table 63. Alfasigma USA (Italy) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Alfasigma USA (Italy) Recent Developments and Future Plans
Table 65. RedHill Biopharma (Israel) Company Information, Head Office, and Major Competitors
Table 66. RedHill Biopharma (Israel) Major Business
Table 67. RedHill Biopharma (Israel) IBS Treatment Product and Solutions
Table 68. RedHill Biopharma (Israel) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. RedHill Biopharma (Israel) Recent Developments and Future Plans
Table 70. AstraZeneca (U.K) Company Information, Head Office, and Major Competitors
Table 71. AstraZeneca (U.K) Major Business
Table 72. AstraZeneca (U.K) IBS Treatment Product and Solutions
Table 73. AstraZeneca (U.K) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. AstraZeneca (U.K) Recent Developments and Future Plans
Table 75. Ipsen (France) Company Information, Head Office, and Major Competitors
Table 76. Ipsen (France) Major Business
Table 77. Ipsen (France) IBS Treatment Product and Solutions
Table 78. Ipsen (France) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Ipsen (France) Recent Developments and Future Plans
Table 80. Novartis (Switzerland) Company Information, Head Office, and Major Competitors
Table 81. Novartis (Switzerland) Major Business
Table 82. Novartis (Switzerland) IBS Treatment Product and Solutions
Table 83. Novartis (Switzerland) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Novartis (Switzerland) Recent Developments and Future Plans
Table 85. Takeda Pharmaceutical Company (Japan) Company Information, Head Office, and Major Competitors
Table 86. Takeda Pharmaceutical Company (Japan) Major Business
Table 87. Takeda Pharmaceutical Company (Japan) IBS Treatment Product and Solutions
Table 88. Takeda Pharmaceutical Company (Japan) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Takeda Pharmaceutical Company (Japan) Recent Developments and Future Plans
Table 90. Synthetic Biologics (U.S.) Company Information, Head Office, and Major Competitors
Table 91. Synthetic Biologics (U.S.) Major Business
Table 92. Synthetic Biologics (U.S.) IBS Treatment Product and Solutions
Table 93. Synthetic Biologics (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Synthetic Biologics (U.S.) Recent Developments and Future Plans
Table 95. Protagonist Therapeutics (U.S.) Company Information, Head Office, and Major Competitors
Table 96. Protagonist Therapeutics (U.S.) Major Business
Table 97. Protagonist Therapeutics (U.S.) IBS Treatment Product and Solutions
Table 98. Protagonist Therapeutics (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Protagonist Therapeutics (U.S.) Recent Developments and Future Plans
Table 100. Pfizer (U.S.) Company Information, Head Office, and Major Competitors
Table 101. Pfizer (U.S.) Major Business
Table 102. Pfizer (U.S.) IBS Treatment Product and Solutions
Table 103. Pfizer (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Pfizer (U.S.) Recent Developments and Future Plans
Table 105. Lexicon Pharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 106. Lexicon Pharmaceuticals (U.S.) Major Business
Table 107. Lexicon Pharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 108. Lexicon Pharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Lexicon Pharmaceuticals (U.S.) Recent Developments and Future Plans
Table 110. Innovate Biopharmaceuticals (U.S.) Company Information, Head Office, and Major Competitors
Table 111. Innovate Biopharmaceuticals (U.S.) Major Business
Table 112. Innovate Biopharmaceuticals (U.S.) IBS Treatment Product and Solutions
Table 113. Innovate Biopharmaceuticals (U.S.) IBS Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Innovate Biopharmaceuticals (U.S.) Recent Developments and Future Plans
Table 115. Global IBS Treatment Revenue (USD Million) by Players (2019-2024)
Table 116. Global IBS Treatment Revenue Share by Players (2019-2024)
Table 117. Breakdown of IBS Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in IBS Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 119. Head Office of Key IBS Treatment Players
Table 120. IBS Treatment Market: Company Product Type Footprint
Table 121. IBS Treatment Market: Company Product Application Footprint
Table 122. IBS Treatment New Market Entrants and Barriers to Market Entry
Table 123. IBS Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global IBS Treatment Consumption Value (USD Million) by Type (2019-2024)
Table 125. Global IBS Treatment Consumption Value Share by Type (2019-2024)
Table 126. Global IBS Treatment Consumption Value Forecast by Type (2025-2030)
Table 127. Global IBS Treatment Consumption Value by Application (2019-2024)
Table 128. Global IBS Treatment Consumption Value Forecast by Application (2025-2030)
Table 129. North America IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 130. North America IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 131. North America IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 132. North America IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 133. North America IBS Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 134. North America IBS Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 135. Europe IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Europe IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Europe IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 138. Europe IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 139. Europe IBS Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 140. Europe IBS Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 141. Asia-Pacific IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 142. Asia-Pacific IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 143. Asia-Pacific IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 144. Asia-Pacific IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 145. Asia-Pacific IBS Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 146. Asia-Pacific IBS Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 147. South America IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 148. South America IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 149. South America IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 150. South America IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 151. South America IBS Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 152. South America IBS Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Middle East & Africa IBS Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 154. Middle East & Africa IBS Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 155. Middle East & Africa IBS Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 156. Middle East & Africa IBS Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 157. Middle East & Africa IBS Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 158. Middle East & Africa IBS Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 159. IBS Treatment Raw Material
Table 160. Key Suppliers of IBS Treatment Raw Materials
LIST OF FIGURES
Figure 1. IBS Treatment Picture
Figure 2. Global IBS Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global IBS Treatment Consumption Value Market Share by Type in 2023
Figure 4. IBS-D
Figure 5. IBS-C
Figure 6. IBS-M
Figure 7. Global IBS Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. IBS Treatment Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Research Laboratories Picture
Figure 12. Global IBS Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global IBS Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market IBS Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global IBS Treatment Consumption Value Market Share by Region (2019-2030)
Figure 16. Global IBS Treatment Consumption Value Market Share by Region in 2023
Figure 17. North America IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 20. South America IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 22. Global IBS Treatment Revenue Share by Players in 2023
Figure 23. IBS Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players IBS Treatment Market Share in 2023
Figure 25. Global Top 6 Players IBS Treatment Market Share in 2023
Figure 26. Global IBS Treatment Consumption Value Share by Type (2019-2024)
Figure 27. Global IBS Treatment Market Share Forecast by Type (2025-2030)
Figure 28. Global IBS Treatment Consumption Value Share by Application (2019-2024)
Figure 29. Global IBS Treatment Market Share Forecast by Application (2025-2030)
Figure 30. North America IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 31. North America IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 32. North America IBS Treatment Consumption Value Market Share by Country (2019-2030)
Figure 33. United States IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe IBS Treatment Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 40. France IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific IBS Treatment Consumption Value Market Share by Region (2019-2030)
Figure 47. China IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 50. India IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 53. South America IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 54. South America IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 55. South America IBS Treatment Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa IBS Treatment Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 64. IBS Treatment Market Drivers
Figure 65. IBS Treatment Market Restraints
Figure 66. IBS Treatment Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of IBS Treatment in 2023
Figure 69. Manufacturing Process Analysis of IBS Treatment
Figure 70. IBS Treatment Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. IBS Treatment Picture
Figure 2. Global IBS Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global IBS Treatment Consumption Value Market Share by Type in 2023
Figure 4. IBS-D
Figure 5. IBS-C
Figure 6. IBS-M
Figure 7. Global IBS Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. IBS Treatment Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Research Laboratories Picture
Figure 12. Global IBS Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global IBS Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market IBS Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global IBS Treatment Consumption Value Market Share by Region (2019-2030)
Figure 16. Global IBS Treatment Consumption Value Market Share by Region in 2023
Figure 17. North America IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 20. South America IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 22. Global IBS Treatment Revenue Share by Players in 2023
Figure 23. IBS Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players IBS Treatment Market Share in 2023
Figure 25. Global Top 6 Players IBS Treatment Market Share in 2023
Figure 26. Global IBS Treatment Consumption Value Share by Type (2019-2024)
Figure 27. Global IBS Treatment Market Share Forecast by Type (2025-2030)
Figure 28. Global IBS Treatment Consumption Value Share by Application (2019-2024)
Figure 29. Global IBS Treatment Market Share Forecast by Application (2025-2030)
Figure 30. North America IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 31. North America IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 32. North America IBS Treatment Consumption Value Market Share by Country (2019-2030)
Figure 33. United States IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe IBS Treatment Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 40. France IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific IBS Treatment Consumption Value Market Share by Region (2019-2030)
Figure 47. China IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 50. India IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 53. South America IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 54. South America IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 55. South America IBS Treatment Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa IBS Treatment Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa IBS Treatment Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa IBS Treatment Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE IBS Treatment Consumption Value (2019-2030) & (USD Million)
Figure 64. IBS Treatment Market Drivers
Figure 65. IBS Treatment Market Restraints
Figure 66. IBS Treatment Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of IBS Treatment in 2023
Figure 69. Manufacturing Process Analysis of IBS Treatment
Figure 70. IBS Treatment Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
